PEPCK-C might participate in specific phases of the tumor progression in adaptative responses that are key to cancer development as it is suggested by its participation in some metabolic adaptations in hepatocarcinoma [22] and melanoma [23]. This evidence concerns the gene PCK1 and melanoma.